Comparative expression pathway analysis of human and canine mammary tumors1IRBM P. Angeletti, Merck MRL-Rome, Via Pontina Km, 30600 Pomezia, Italy 2Department of Molecular Profiling, Merck Research Laboratories, West Point, Pennsylvania, USA 3Rosetta Inpharmatics LLC, a wholly owned subsidiary of Merck and Co Inc., Terry Avenue North, Seattle, WA 98109, USA 4Department of Public Health, Veterinary Hygiene and Comparative Pathology, University of Padua, Italy 5Clinica Veterinaria L'Arca, Vico Cacciottoli 46/47, 80129 Naples, Italy 6Department of Animal Pathology, University of Pisa, Italy
BMC Genomics 2009, 10:135doi:10.1186/1471-2164-10-135
Additional filesAdditional file 1: Description of 33 canine mammary samples. Pathological information and classification (normal, benign, intermediate, malignant) of 33 canine mammary samples extracted from 10 different animals. Malignant mammary tumours were further classified based on the tumour aggressiveness in M1 (infiltrating/solid), M2 (simple) and M3 (complex). Format: XLS Size: 32KB Download file This file can be viewed with: Microsoft Excel Viewer Additional file 2: Description of 129 human mammary samples. Information regarding sample classification, tumour size, tumour stage and percentage of tumor cells of the 129 human mammary samples. Format: XLS Size: 23KB Download file This file can be viewed with: Microsoft Excel Viewer Additional file 3: List of 1043 group-specific genes selected by ANOVA in dog dataset. – worksheet '1043 AN0VA': genes identified as differentially expressed among the three groups of dog mammary samples (M, malignant; I-B, intermediate-benign; N, normal) (ANOVA, q-value < 0.001). – worksheet 'enrichment analysis': results of the gene set enrichment analysis separately run on each of the six groups identified based on their pattern of expression. Format: XLS Size: 338KB Download file This file can be viewed with: Microsoft Excel Viewer Additional file 4: Identification of genes most correlated to the 1st principal component and results of gene set enrichment analysis. Results of the gene set enrichment analysis of the genes most correlated to the 1st principal component. The correlations of the genes with the 1st principal component were transformed to SDs from the mean, then genes with values > 1.5 (positive correlation) or < -1.5 (negative correlation) were selected. These genes were analyzed separately by gene set enrichment analysis. Format: XLS Size: 601KB Download file This file can be viewed with: Microsoft Excel Viewer Additional file 5: Tumour deregulated genes in human and dog datasets. Genes identified as differentially expressed between tumor and pool of normal samples in human and dog datasets (t-test, q-value < 0.001). Format: XLS Size: 2.1MB Download file This file can be viewed with: Microsoft Excel Viewer Additional file 6: Gene set enrichment analysis of tumor deregulated genes. Results of gene set enrichment analysis of tumor deregulated genes in human and dog. Gene sets that were enriched (p < 0.05) in at least one dataset are shown. Format: XLS Size: 2.3MB Download file This file can be viewed with: Microsoft Excel Viewer Additional file 7: Correlation between prognostic and oncogenic signatures in human breast tumors. Graphical representation of the pair wise Pearson correlation in the human tumor dataset between all the "oncogenic" and "prognostic" signatures described in Table 1. Signatures are ordered by agglomerative hierarchical clustering based on Pearson coefficients. Format: TIFF Size: 3.1MB Download file Additional file 8: Correlation between prognostic and oncogenic signatures in canine mammary tumors. Graphical representation of the pair wise Pearson correlation in the canine tumor dataset between all the "oncogenic" and "prognostic" signatures described in Table 1. Samples are ordered according to the hierarchical clustering computed on human tumors (Additional file 9). Format: TIFF Size: 3.2MB Download file Additional file 9: Consent guidelines. Guidelines followed by Genomics Collaborative, Inc. for obtaining patients informed consent. Format: DOC Size: 29KB Download file This file can be viewed with: Microsoft Word Viewer Additional file 10: Consent Module. Informed consent module delivered by Genomics Collaborative, Inc to patients who contributed to the collection human tissue samples. Format: DOC Size: 40KB Download file This file can be viewed with: Microsoft Word Viewer Additional file 11: Log10 of the ratio Tumor vs Pool of Normal for 9,963 dog-human orthologous genes. Contains a tab-delimited file with the normalized log10ratio for the 9,963 dog-human orthologous genes across the 162 samples. Format: ZIP Size: 8.1MB Download file Additional file 12: Error associated to the log10 of the ratio Tumor vs Pool of Normal for 9,963 dog-human orthologous genes. Tab-delimited file with the error associated to the log10ratio for the 9,963 dog-human orthologous genes across the 162 samples. Format: ZIP Size: 7.4MB Download file Additional file 13: Rosetta p-value associated to the log10 of the ratio Tumor vs Pool of Normal for 9,963 dog-human orthologous genes. Tab-delimited file with the Rosetta p-values of differential expression for the 9,963 dog-human orthologous genes across the 162 samples. Format: ZIP Size: 8.2MB Download file |




on Google Scholar








author email
corresponding author email